Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care.

J Community Genet · 2022 · PMC8628132 · PMID 34843087

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

weakly significantno p-value reported

POG patients who experienced biopsy failure had a weakly significant incremental 1-year survival loss of 1.39 months (95% CI: − 2.89, − 0.01) compared to usual care patients.

also in 1,387 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.